Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash to Debt 0.85
WMGI's Cash to Debt is ranked lower than
66% of the 319 Companies
in the Global Medical Devices industry.

( Industry Median: 2.56 vs. WMGI: 0.85 )
Ranked among companies with meaningful Cash to Debt only.
WMGI' s 10-Year Cash to Debt Range
Min: 0.06  Med: 1.20 Max: N/A
Current: 0.85
Equity to Asset 0.21
WMGI's Equity to Asset is ranked lower than
91% of the 282 Companies
in the Global Medical Devices industry.

( Industry Median: 0.66 vs. WMGI: 0.21 )
Ranked among companies with meaningful Equity to Asset only.
WMGI' s 10-Year Equity to Asset Range
Min: -0.4  Med: 0.62 Max: 0.83
Current: 0.21
-0.4
0.83
F-Score: 3
Z-Score: 0.29
M-Score: -2.99
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 3/10

vs
industry
vs
history
Operating margin (%) -36.04
WMGI's Operating margin (%) is ranked lower than
71% of the 302 Companies
in the Global Medical Devices industry.

( Industry Median: 3.12 vs. WMGI: -36.04 )
Ranked among companies with meaningful Operating margin (%) only.
WMGI' s 10-Year Operating margin (%) Range
Min: -116.46  Med: 5.22 Max: 13.22
Current: -36.04
-116.46
13.22
Net-margin (%) -91.51
WMGI's Net-margin (%) is ranked lower than
75% of the 302 Companies
in the Global Medical Devices industry.

( Industry Median: 1.99 vs. WMGI: -91.51 )
Ranked among companies with meaningful Net-margin (%) only.
WMGI' s 10-Year Net-margin (%) Range
Min: -113.05  Med: 1.58 Max: 12.48
Current: -91.51
-113.05
12.48
ROE (%) -75.80
WMGI's ROE (%) is ranked lower than
87% of the 287 Companies
in the Global Medical Devices industry.

( Industry Median: 3.14 vs. WMGI: -75.80 )
Ranked among companies with meaningful ROE (%) only.
WMGI' s 10-Year ROE (%) Range
Min: -70.33  Med: 1.96 Max: 15.55
Current: -75.8
-70.33
15.55
ROA (%) -27.44
WMGI's ROA (%) is ranked lower than
69% of the 321 Companies
in the Global Medical Devices industry.

( Industry Median: -0.33 vs. WMGI: -27.44 )
Ranked among companies with meaningful ROA (%) only.
WMGI' s 10-Year ROA (%) Range
Min: -27.94  Med: 0.62 Max: 10.66
Current: -27.44
-27.94
10.66
ROC (Joel Greenblatt) (%) -74.89
WMGI's ROC (Joel Greenblatt) (%) is ranked lower than
65% of the 316 Companies
in the Global Medical Devices industry.

( Industry Median: 3.55 vs. WMGI: -74.89 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
WMGI' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -99.14  Med: 8.62 Max: 23.13
Current: -74.89
-99.14
23.13
Revenue Growth (3Y)(%) -23.50
WMGI's Revenue Growth (3Y)(%) is ranked lower than
88% of the 194 Companies
in the Global Medical Devices industry.

( Industry Median: 2.90 vs. WMGI: -23.50 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
WMGI' s 10-Year Revenue Growth (3Y)(%) Range
Min: 0  Med: 2.50 Max: 14.8
Current: -23.5
0
14.8
EPS Growth (3Y)(%) 233.70
WMGI's EPS Growth (3Y)(%) is ranked higher than
96% of the 173 Companies
in the Global Medical Devices industry.

( Industry Median: -0.40 vs. WMGI: 233.70 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
WMGI' s 10-Year EPS Growth (3Y)(%) Range
Min: 0  Med: -7.55 Max: 233.7
Current: 233.7
0
233.7
» WMGI's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2014

WMGI Guru Trades in Q2 2014

Columbia Wanger 137,038 sh (New)
Mario Gabelli 211,000 sh (unchged)
Steven Cohen 635,100 sh (unchged)
Paul Tudor Jones Sold Out
Michael Price Sold Out
Ken Fisher 2,389,299 sh (-0.96%)
John Keeley 1,346,781 sh (-3.04%)
» More
Q3 2014

WMGI Guru Trades in Q3 2014

Paul Tudor Jones 300,000 sh (New)
Columbia Wanger 944,900 sh (+589.52%)
Mario Gabelli 211,000 sh (unchged)
John Keeley 1,345,231 sh (-0.12%)
Ken Fisher 2,371,254 sh (-0.76%)
Steven Cohen 316,300 sh (-50.20%)
» More
Q4 2014

WMGI Guru Trades in Q4 2014

Jim Simons 429,463 sh (New)
Steven Cohen 861,800 sh (+172.46%)
Columbia Wanger 1,757,600 sh (+86.01%)
John Keeley 1,787,091 sh (+32.85%)
Ken Fisher 2,350,279 sh (unchged)
Mario Gabelli 211,000 sh (unchged)
Ken Fisher 2,350,279 sh (-0.88%)
Paul Tudor Jones 50,000 sh (-83.33%)
» More
Q1 2015

WMGI Guru Trades in Q1 2015

Paul Tudor Jones 100,000 sh (+100.00%)
Columbia Wanger 2,299,600 sh (+30.84%)
John Keeley 1,848,121 sh (+3.42%)
Mario Gabelli 211,000 sh (unchged)
Ken Fisher 2,316,764 sh (-1.43%)
Jim Simons 182,327 sh (-57.55%)
Steven Cohen 123,600 sh (-85.66%)
» More
» Details

Insider Trades

Latest Guru Trades with WMGI

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 5.53
WMGI's P/B is ranked lower than
74% of the 288 Companies
in the Global Medical Devices industry.

( Industry Median: 3.13 vs. WMGI: 5.53 )
Ranked among companies with meaningful P/B only.
WMGI' s 10-Year P/B Range
Min: 1.09  Med: 2.27 Max: 5.75
Current: 5.53
1.09
5.75
P/S 4.38
WMGI's P/S is ranked lower than
63% of the 291 Companies
in the Global Medical Devices industry.

( Industry Median: 3.19 vs. WMGI: 4.38 )
Ranked among companies with meaningful P/S only.
WMGI' s 10-Year P/S Range
Min: 0.96  Med: 2.44 Max: 6.12
Current: 4.38
0.96
6.12
Current Ratio 3.53
WMGI's Current Ratio is ranked higher than
60% of the 311 Companies
in the Global Medical Devices industry.

( Industry Median: 2.69 vs. WMGI: 3.53 )
Ranked among companies with meaningful Current Ratio only.
WMGI' s 10-Year Current Ratio Range
Min: 1.87  Med: 4.20 Max: 8.53
Current: 3.53
1.87
8.53
Quick Ratio 3.01
WMGI's Quick Ratio is ranked higher than
64% of the 311 Companies
in the Global Medical Devices industry.

( Industry Median: 2.03 vs. WMGI: 3.01 )
Ranked among companies with meaningful Quick Ratio only.
WMGI' s 10-Year Quick Ratio Range
Min: 1.12  Med: 3.18 Max: 7.78
Current: 3.01
1.12
7.78
Days Inventory 422.96
WMGI's Days Inventory is ranked lower than
94% of the 281 Companies
in the Global Medical Devices industry.

( Industry Median: 131.50 vs. WMGI: 422.96 )
Ranked among companies with meaningful Days Inventory only.
WMGI' s 10-Year Days Inventory Range
Min: 86.05  Med: 332.57 Max: 840.1
Current: 422.96
86.05
840.1
Days Sales Outstanding 63.16
WMGI's Days Sales Outstanding is ranked higher than
60% of the 272 Companies
in the Global Medical Devices industry.

( Industry Median: 68.21 vs. WMGI: 63.16 )
Ranked among companies with meaningful Days Sales Outstanding only.
WMGI' s 10-Year Days Sales Outstanding Range
Min: 53.19  Med: 71.90 Max: 81.85
Current: 63.16
53.19
81.85

Valuation & Return

vs
industry
vs
history
Price/Median PS Value 1.80
WMGI's Price/Median PS Value is ranked lower than
81% of the 261 Companies
in the Global Medical Devices industry.

( Industry Median: 1.13 vs. WMGI: 1.80 )
Ranked among companies with meaningful Price/Median PS Value only.
WMGI' s 10-Year Price/Median PS Value Range
Min: 0.43  Med: 1.07 Max: 2.37
Current: 1.8
0.43
2.37
Earnings Yield (Greenblatt) (%) -7.58
WMGI's Earnings Yield (Greenblatt) (%) is ranked lower than
69% of the 309 Companies
in the Global Medical Devices industry.

( Industry Median: 0.50 vs. WMGI: -7.58 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
WMGI' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: -7.66  Med: 3.20 Max: 8.9
Current: -7.58
-7.66
8.9
Forward Rate of Return (Yacktman) (%) -10.29
WMGI's Forward Rate of Return (Yacktman) (%) is ranked lower than
80% of the 99 Companies
in the Global Medical Devices industry.

( Industry Median: 4.13 vs. WMGI: -10.29 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
WMGI' s 10-Year Forward Rate of Return (Yacktman) (%) Range
Min: -15.7  Med: 0.80 Max: 18.5
Current: -10.29
-15.7
18.5

Business Description

Industry: Medical Devices » Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ » details
Traded in other countries:WM3.Germany,
Wright Medical Group Inc, through Wright Medical Technology, Inc. and other operating subsidiaries, is a specialty orthopaedic company, that provides extremity and biologic solutions that enable clinicians to alleviate pain and restore their patients' lifestyles. The Company provides surgical solutions for the foot and ankle market and markets its products in over 60 countries. Its business includes products that are used in foot and ankle repair, upper extremity products, and biologics products, which are used to replace damaged or diseased bone, to stimulate bone growth and to provide other biological solutions for surgeons and their patients. Extremity hardware includes implants and other devices to replace or reconstruct injured or diseased joints and bones of the foot, ankle, hand, wrist, fingers, toes, elbow and shoulder, which it generally refer to as either foot and ankle or upper extremity products. The Company's manufacturing and warehousing operations are located in Arlington, Tennessee. Outside the U.S., The Company has distribution and administrative facilities in Amsterdam, the Netherlands, and sales and distribution offices in Canada, Australia, and Europe. The Company operates its continuing operations as one reportable segment and offer products in extremity reconstruction and biologics. The Company's products include CHARLOTTE, CLAW II, DARCO, EVOLVE, MICRONAIL, GRAFTJACKET, OSTEOSET. Its competitors include major companies in the orthopaedic and biologics industries, as well as academic institutions and other public and private research organizations that continue to conduct research, seek patent protection and establish arrangements for commercializing products. The Company's products are strictly regulated by the FDA under the Food, Drug, and Cosmetic Act. Some of its products are also regulated by state agencies.
» More Articles for WMGI

Headlines

Articles On GuruFocus.com
Wright Medical Group Inc. Reports Operating Results (10-Q) Oct 29 2010 
Wright Medical Group Inc. Reports Operating Results (10-Q) Aug 03 2010 
Wright Medical Group Inc. (WMGI) Sr. VP & CFO Lance A Berry sells 1,015 Shares May 19 2010 
Wright Medical Group Inc. (WMGI) President and CEO Gary D Henley sells 2,266 Shares May 19 2010 
Wright Medical Group Inc. (WMGI) President and CEO Gary D Henley sells 4,950 Shares May 17 2010 
Wright Medical Group Inc. (WMGI) Sr. VP & CFO Lance A Berry sells 1,260 Shares May 17 2010 
Wright Medical Group Inc. Reports Operating Results (10-Q) May 05 2010 
Wright Medical Group Inc. (WMGI) Exec. VP & CFO John K Bakewell sells 9,249 Shares Dec 04 2009 
Wright Medical Group Inc. Reports Operating Results (10-Q) Oct 30 2009 
Wright Medical Group Inc. Reports Operating Results (10-Q) Aug 04 2009 

More From Other Websites
Wright Medical-Tornier Merger Wins Shareholders' Approval - Analyst Blog Jun 19 2015
WRIGHT MEDICAL GROUP INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jun 18 2015
Wright Medical and Tornier Shareholders Approve All Proposals Related to Merger Jun 18 2015
Wright Medical and Tornier Shareholders Approve All Proposals Related to Merger Jun 18 2015
Wright Medical and Tornier Shareholders Approve All Proposals Related to Merger Jun 18 2015
KYTH up 26.7% over past day, pushes Palo Alto Investors Forward Jun 18 2015
WRIGHT MEDICAL GROUP INC Files SEC form 8-K, Other Events May 29 2015
Wright Medical Group, Inc. to Present at Jefferies 2015 Global Healthcare Conference May 20 2015
Coverage initiated on Wright Medical by Northland Capital May 14 2015
Wright and Tornier Shareholder Meetings Scheduled for June 18, 2015 May 14 2015
Wright Medical Group, Inc. to Present at Jefferies 2015 Global Healthcare Conference May 14 2015
Wright and Tornier Shareholder Meetings Scheduled for June 18, 2015 May 07 2015
10-Q for Wright Medical Group, Inc. May 04 2015
Club for Growth takes aim at Fincher over Export-Import Bank May 04 2015
Wright Medical Q1 Loss Wider than Expected, Sales Up Y/Y - Analyst Blog Apr 30 2015
Ankle business boosts Wright Medical's first quarter Apr 30 2015
WRIGHT MEDICAL GROUP INC Files SEC form 10-Q, Quarterly Report Apr 30 2015
Wright Medical Group, Inc. to Host First Quarter 2015 Earnings Conference Call Apr 29 2015
Wright Medical reports 1Q loss Apr 29 2015
Wright Medical reports 1Q loss Apr 29 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK